BioXcel Therapeutics Inc (BTAI)
2.57
+0.01
(+0.39%)
USD |
NASDAQ |
May 03, 16:00
2.57
0.00 (0.00%)
After-Hours: 20:00
BioXcel Therapeutics Total Liabilities (Quarterly): 130.21M for Dec. 31, 2023
Total Liabilities (Quarterly) Chart
Historical Total Liabilities (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | 130.21M |
| September 30, 2023 | 141.06M |
| June 30, 2023 | 134.23M |
| March 31, 2023 | 127.10M |
| December 31, 2022 | 129.08M |
| September 30, 2022 | 117.83M |
| June 30, 2022 | 83.97M |
| March 31, 2022 | 17.02M |
| December 31, 2021 | 17.77M |
| September 30, 2021 | 15.78M |
| June 30, 2021 | 13.70M |
| March 31, 2021 | 13.65M |
| December 31, 2020 | 13.24M |
| Date | Value |
|---|---|
| September 30, 2020 | 17.81M |
| June 30, 2020 | 17.07M |
| March 31, 2020 | 13.23M |
| December 31, 2019 | 9.497M |
| September 30, 2019 | 9.277M |
| June 30, 2019 | 9.121M |
| March 31, 2019 | 7.96M |
| December 31, 2018 | 4.66M |
| September 30, 2018 | 2.043M |
| June 30, 2018 | 1.389M |
| March 31, 2018 | 4.215M |
| December 31, 2017 | 2.337M |
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
9.121M
Minimum
Jun 2019
141.06M
Maximum
Sep 2023
54.24M
Average
17.07M
Median
Jun 2020
Total Liabilities (Quarterly) Benchmarks
| Synlogic Inc | 32.90M |
| Cormedix Inc | 11.92M |
| Bristol-Myers Squibb Co | 82.48B |
| Verastem Inc | 92.34M |
| Ocular Therapeutix Inc | 160.93M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 73.70M |
| Shareholders Equity (Quarterly) | -56.51M |
| Debt to Equity Ratio | -1.780 |
| Current Ratio | 2.646 |
| Net Debt Paydown Yield | -2.02% |